SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1019It looks like NIH will be late announcing results from the Phase II trial. ResuJMarcus-12/28/2000
1018Hi JM, Thanks for the up to date info. Unfortunately who would have anticipateBRAVEHEART-12/14/2000
1017Hello old Friends, John & Tuck etc. Tuck NTII is legit...Not a P&D. TBRAVEHEART-12/14/2000
1016Paul Freiman made the following comments about Nexus Capital at the stockholdersJMarcus-12/4/2000
1015Tuck, as you've probably found already, there's been some discussion of tom pope-12/2/2000
1014Tuck, Please, no apologies! I wasn't trying to say anything in particular sim1-12/1/2000
1013Stuart, That link isn't producing anything for me. What are you trying to tuck-12/1/2000
1012>>I don't know this company.<< [New York-based Nexus Health Capisim1-12/1/2000
1011NTII shopping itself? I don't know this company. biz.yahoo.com Cheers, Ttuck-12/1/2000
1010Thanks for a great job summarizing the NTII meeting. Happy Thanksgiving!BulbaMan-11/22/2000
1009Jmarcus Thanks for sharing the detailed information for those of us that couldnCraig S. Owens-11/22/2000
1008I attended my third straight annual stockholders meeting of NTII today. Once agJMarcus-11/21/2000
1007No question but Freiman gets to work early. biz.yahoo.comtom pope-11/11/2000
1006Neurobiological Technologies Receives $2.5 Million Payment for Memantine biz.yDr. John M. de Castro-11/1/2000
1005Pfizer Suspends Development on Diabetic Nerve Drug By Tsim1-10/16/2000
1004Freiman's history is very clear and revealing. He took Syntek from a strugglDr. John M. de Castro-9/27/2000
1003>> Paul Freiman reiterated that NTII is exploring three alternatives: (1) BulbaMan-9/27/2000
1002John McCarthy posted a nice summary of the CC on the Yahoo! thread at messages.yJMarcus-9/26/2000
1001Notes from the conference call: -- NTII expects to hear "shortly" froJMarcus-9/26/2000
1000Neurobiological Technologies, Inc. (Nasdaq: NTII) Announces Fourth Quarter On-LiDr. John M. de Castro-9/25/2000
999From Chicago, with love of memantine..:) Psychopharmacology (Berl) 2000 Aug;151Neuroguy-9/13/2000
998From Russia, with love of memantine The attached abstract reviews a basic, animDr. John M. de Castro-9/13/2000
997I'm back and nothing significant happened to NTII. But, as always seems to oDr. John M. de Castro-9/11/2000
996John - well that's a relief! Have a great vacation. Let's hope this is Neuroguy-9/8/2000
995Warning, significant activity indicator! All, I'm leaving to go on vacation Dr. John M. de Castro-9/2/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News